| Title |
Product Quality Research Initiative and Bulk Actives Post Approval Change
|
|---|---|
| Published in |
Therapeutic Innovation & Regulatory Science, December 1999
|
| DOI | 10.1177/009286159903300317 |
| Authors |
Daniel H. Gold, Stephen Byrn |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2015.
All research outputs
#8,535,684
of 25,377,790 outputs
Outputs from Therapeutic Innovation & Regulatory Science
#249
of 861 outputs
Outputs of similar age
#24,732
of 109,338 outputs
Outputs of similar age from Therapeutic Innovation & Regulatory Science
#3
of 16 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 861 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,338 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.